Literature DB >> 33505756

A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap Syndrome.

Hiroyuki Hounoki1, Koichiro Shinoda1, Atsushi Matsui1, Maiko Okumura1, Satoshi Yamaguchi1, Kota Kakeshita2, Hidenori Yamazaki2, Tsutomu Koike2, Teruhiko Makino3, Kazuyuki Tobe1.   

Abstract

An overlap of systemic lupus erythematosus (SLE) and antineutrophil cytoplasmic antibodies- (ANCA-) associated vasculitis (AAV) is extremely rare: approximately 40 cases have been reported to date. A literature review indicates that they are more common in women in their forties, and simultaneous onset has been reported in 69% of cases. In addition, both lupus nephritis and ANCA-associated glomerulonephritis were observed on renal biopsy. This report presents the case of a 35-year-old woman with an 8-month history of polyarthralgia who was admitted to our hospital. She was diagnosed with SLE due to typical clinical presentation of the disease: polyarthritis, lymphocytopenia, hypocomplementemia, presence of antinuclear and anti-dsDNA antibodies, and proteinuria. However, purpura were scattered, and the titer of antimyeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) was high. A skin biopsy revealed leukocytoclastic vasculitis that involved poor immune complex deposition. A renal biopsy showed necrotizing glomerulonephritis with cellular and fibrocellular crescent formation that involved deposition of IgM and C3c only in the mesangial area and the peripheral capillaries. Additionally, no electron-dense deposits were observed under electron microscopy. These pathological findings were consistent with AAV rather than with SLE. Therefore, we finally diagnosed the patient with both SLE and microscopic polyangiitis. After treatment with methylprednisolone and intravenous cyclophosphamide pulse therapies, renal function improved and MPO-ANCA levels decreased. In cases of suspected overlap between SLE and AAV, appropriate diagnosis and treatment are important.
Copyright © 2021 Hiroyuki Hounoki et al.

Entities:  

Year:  2021        PMID: 33505756      PMCID: PMC7808812          DOI: 10.1155/2021/6690658

Source DB:  PubMed          Journal:  Case Rep Rheumatol        ISSN: 2090-6897


  20 in total

1.  Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.

Authors:  K Nishiya; H Chikazawa; S Nishimura; N Hisakawa; K Hashimoto
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

Review 2.  Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus.

Authors:  D Sen; David A Isenberg
Journal:  Lupus       Date:  2003       Impact factor: 2.911

3.  Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Daigo Nakazawa; Utano Tomaru; Akira Suzuki; Sakiko Masuda; Risa Hasegawa; Toshiaki Kobayashi; Saori Nishio; Masanori Kasahara; Akihiro Ishizu
Journal:  Arthritis Rheum       Date:  2012-11

4.  Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies.

Authors:  A Chang; O Aneziokoro; S M Meehan; R J Quigg
Journal:  Kidney Int       Date:  2006-10-11       Impact factor: 10.612

Review 5.  Vasculitis in systemic lupus erythematosus.

Authors:  L Barile-Fabris; M F Hernández-Cabrera; J A Barragan-Garfias
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

6.  Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis.

Authors:  Daigo Nakazawa; Haruki Shida; Utano Tomaru; Masaharu Yoshida; Saori Nishio; Tatsuya Atsumi; Akihiro Ishizu
Journal:  J Am Soc Nephrol       Date:  2014-01-02       Impact factor: 10.121

7.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Authors:  Samih H Nasr; Vivette D D'Agati; Hye-Ran Park; Paul L Sterman; Juan D Goyzueta; Robert M Dressler; Shawn M Hazlett; Robert N Pursell; Christopher Caputo; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

8.  Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.

Authors:  Mark A Little; Lucy Smyth; Alan D Salama; Sriparna Mukherjee; Jennifer Smith; Dorian Haskard; Sussan Nourshargh; H Terence Cook; Charles D Pusey
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

9.  Introducing polyautoimmunity: secondary autoimmune diseases no longer exist.

Authors:  Adriana Rojas-Villarraga; Jenny Amaya-Amaya; Alberto Rodriguez-Rodriguez; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2012-02-20

10.  Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Authors:  Pierre-Andre Jarrot; Laurent Chiche; Baptiste Hervier; Laurent Daniel; Vincent Vuiblet; Nathalie Bardin; Daniel Bertin; Benjamin Terrier; Zahir Amoura; Emmanuel Andrés; Eric Rondeau; Mohamed Hamidou; Jean-Loup Pennaforte; Philippe Halfon; Eric Daugas; Bertrand Dussol; Xavier Puéchal; Gilles Kaplanski; Noemie Jourde-Chiche
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more
  1 in total

1.  Diagnosing and Managing Clinically Silent Lupus Nephritis and Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome: A Clinical Challange.

Authors:  Aqsa Ashraf; Jordan Daloya; Vishal Rana; Aitezaz Ahmed; Alan Kaell
Journal:  Cureus       Date:  2022-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.